- Report
- January 2022
- 40 Pages
Japan
From €1421EUR$1,500USD£1,200GBP
- Report
- January 2022
- 40 Pages
Russia
From €1421EUR$1,500USD£1,200GBP
- Report
- January 2022
- 40 Pages
South Korea
From €1421EUR$1,500USD£1,200GBP
- Report
- January 2022
- 40 Pages
United States
From €1421EUR$1,500USD£1,200GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €1421EUR$1,500USD£1,200GBP
- Report
- March 2025
- 45 Pages
Global
From €280EUR$295USD£236GBP
- Report
- May 2023
- 249 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- September 2024
- 280 Pages
Global
From €2516EUR$2,655USD£2,123GBP
- Report
- July 2024
- 280 Pages
Global
From €2516EUR$2,655USD£2,123GBP
- Report
- December 2023
- 290 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- November 2023
- 272 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- December 2022
- 240 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- October 2022
- 236 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- October 2022
- 274 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- May 2022
- 270 Pages
Global
From €3383EUR$3,570USD£2,855GBP
- Report
- February 2022
- 258 Pages
Global
From €3517EUR$3,712USD£2,968GBP
- Report
- February 2022
- 227 Pages
Global
From €3517EUR$3,712USD£2,968GBP
- Report
- March 2021
- 202 Pages
Global
From €3463EUR$3,654USD£2,922GBP
- Book
- December 2019
- 432 Pages
- Book
- November 2019
- 432 Pages

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more